Aevis Victoria S.A.
Aevis Victoria S.A. (AEVS.SW) Stock Overview
Explore Aevis Victoria S.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.1B
P/E Ratio
-398.28
EPS (TTM)
$-0.03
ROE
-0.01%
AEVS.SW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Aevis Victoria S.A. (AEVS.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 52.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.21.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -398.28 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 22 hospitals with 1,496 beds; manages with a total of 941 rooms with a total rentable surface of 188,109 sqm. It also provides telemedicine, and ambulance and day clinic services. In addition, it engages in the patient hotel, better aging, radiology institute, pharmacy, ophthalmology, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.
Fabrice Zumbrunnen
4,731
Rue Georges-Jordil 4, Fribourg
2001